Effect Size Analysis of Influenza Testing and Specimen Detection before and after the COVID-19 Pandemic. by Nadia Nisar (311028)

Subjects:

Linear mixed model results, fixed effects for time points, group, time points x group and univariate effects in the two groups WAD grades 2 and 3. by Anneli Peolsson (7867601)

Subjects:

Primary and secondary efficacy end points (intention-to-treat population). by Benjamin R. Lewis (22279166)

Subjects:

Frontier analysis of injuries’ burden caused by fire, heat, and hot substances from 1990 to 2021. by Shi Huang (125861)

Scaling of overall health burden with yearly expenditure growth. by Margherita Molaro (17803989)

Subjects:

nsP4-C483Y or Q192L mutations decrease sensitivity to 4′-FlU. by Peiqi Yin (6533747)

Arctigenin decreased proliferation in colorectal cancer cells with no significant effect on normal cells. by Xiang-Fan Chen (13932983)

Summary of five key points guiding the Safe Steps evaluation and implementation. by Esario IV Daguman (21474116)

Subjects:

Schematic diagram of experimental injector size. by Lei Bai (631944)

Subjects:

Linear mixed model results, fixed effects for time points, group, time points x group and univariate effects in the neck-specific exercise with internet support (NSEIT) group and t... by Anneli Peolsson (7867601)

Subjects:

Significantly Enriched Pathways. by Jiyong Zhang (2498740)

Subjects:

Join-point regression analysis of the statistically significant linear increase in use of antidepressants during the observed time period. by Jelena Filimonovic (22305307)

Transepithelial resistance of NHBE decreases significantly after PAA exposure. by Ellie S. Burns (21246537)

Sampling point (Source: by Yonggang Huang (223155)

ASDR of Tuberculosis for the 21 Global Burden of Disease regions by SDI, 1990-2021. by Xue Li (285380)

Subjects:

ASMR of Tuberculosis for the 21 Global Burden of Disease regions by SDI, 1990-2021. by Xue Li (285380)

Subjects:

Middle cerebral artery mean flow velocity at three time points. by Marco Carbonara (11483575)

Subjects:

Comparison of all–age cases with age–standardized incidence, prevalence,deaths, and DALYs in global men and women, 1990–2021. by Zhengpeng Li (2322058)

Subjects:

Comparison of the number of incidence, prevalence, deaths and DALYs counts by age group and their crude ratios in China in 1990 and 2021. by Zhengpeng Li (2322058)

Subjects:

Comparison of ASIR, ASPR, ASMR and ASDR trends in China and global RA from 1990 to 2021. by Zhengpeng Li (2322058)

Subjects: